Performance status is crucial for several reasons. Firstly, it helps in treatment planning, allowing oncologists to tailor therapies that are appropriate for the patient's current health and ability to tolerate treatment. Secondly, it serves as a prognostic indicator, providing insights into the likely course of the disease. Lastly, it aids in clinical trials by ensuring that participants meet specific criteria, thus ensuring the reliability of study results.
